Wire · operational-macro
Boston Scientific names COO amid cardiovascular restructuring
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 10 October 2026 · Fusion42 review
Boston Scientific will restructure its businesses into three separate reporting segments, splitting its cardiovascular group into Interventional Therapies and Rhythm Solutions, and promoting Joseph Fitzgerald to COO. The restructure aims to create greater focus on long-term growth and faster response to customers, alongside leadership changes in key segments following recent acquisitions and retirements.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Your Medtech venture faces a more focused competitor in Boston Scientific as they split cardiovascular units and boost operational leadership. This reorganisation signals sharper market moves and delivery speed that could squeeze rivals and open gaps for nimble players.
◆ Coverage
1 source · 8 Oct 2026
◆ Related on Wire
◆ Topics